Bio-Bridge Science to Present at Rodman & Renshaw 10th Annual Healthcare Conference on November 12
November 05 2008 - 9:23AM
Business Wire
Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company
engaged in the commercial development of vaccines for the
prevention and treatment of human infectious diseases, announced
today that Dr. Liang Qiao, the Company�s chief executive officer,
will present at the Rodman & Renshaw 10th Annual Healthcare
Conference, on Wednesday, November 12, 2008, at 9:30 a.m. Eastern
time in the Louis room at the Palace Hotel, New York City. The
presentation will give an overview of the Company, a summary of its
strategic plan, as well as, discuss recent events such as the
completion of an acquisition of Xinheng Baide Biotechnology and the
execution of a Memorandum of Understanding to form a Joint Venture
in China. This press release contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange
Commission. All such forward-looking statements, whether written or
oral, and whether made by or on behalf of the company, are
expressly qualified by these cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof. Please refer to the Company's
SEC filings for additional information.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024